Skip to main content
TIBET AIM PHARM. INC. logo

TIBET AIM PHARM. INC. — Investor Relations & Filings

Ticker · 002826 ISIN · CNE100002C39 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,085 across all filing types
Latest filing 2018-01-15 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002826

About TIBET AIM PHARM. INC.

https://www.emyy.cn

Tibet Aim Pharm. Inc. is a pharmaceutical enterprise focused on the research, development, production, and distribution of medicinal products. The company integrates traditional Tibetan medicine with modern pharmaceutical manufacturing processes to develop a diverse portfolio of treatments. Its core product range typically includes cardiovascular medications, digestive system therapies, and specialized herbal formulations derived from high-altitude botanical sources. Tibet Aim Pharm. Inc. emphasizes the modernization of traditional formulas through rigorous clinical testing and standardized production techniques. The company serves healthcare providers and patients by providing therapeutic solutions that bridge ancient medical knowledge with contemporary scientific standards.

Recent filings

Filing Released Lang Actions
股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding abnormal stock price fluctuations of the company 西藏易明西雅医药科技股份有限公司. It explains the situation, confirms no undisclosed material information, and provides risk warnings to investors. There is no financial data, no report attached or referenced as being published, and no mention of management changes, dividends, or other report types. This type of announcement is a regulatory disclosure about stock trading activity and compliance with disclosure rules, fitting the category of a Regulatory Filing (RNS). The document length is short (1177 characters), and it is clearly an announcement rather than a full report or financial statement.
2018-01-15 Chinese
自然人股东减持股份预披露公告
Director's Dealing Classification · 100% confidence The document is a public announcement regarding a natural person shareholder's plan to reduce their shareholding in the company. It details the shareholder's identity, shareholding percentage, reduction plan, reasons, and compliance with relevant securities laws and regulations. There is no financial data, earnings information, or report content. The document is a regulatory announcement about a director's or former director's share transactions (share reduction). This fits the definition of Director's Dealing (DIRS). The document length is short and focused on shareholding changes by a director, not a full report or announcement of a report publication.
2018-01-11 Chinese
关于持股5%以上股东减持计划实施完成的公告
Major Shareholding Notification Classification · 100% confidence The document is an announcement regarding the completion of a shareholding reduction plan by a shareholder holding more than 5% of the company's shares. It details the reduction schedule, quantities, prices, and confirms compliance with relevant securities laws and regulations. There is no financial report, earnings data, or management discussion. The content fits the definition of a Major Shareholding Notification, specifically reporting a change in significant share ownership levels.
2018-01-11 Chinese
股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding abnormal stock price fluctuations for the company 西藏易明西雅医药科技股份有限公司. It explains the situation, confirms no undisclosed material information, and provides risk warnings to investors. There is no financial data, no report attached or referenced as being published, and no mention of management changes, dividends, or other report types. This type of announcement is a regulatory disclosure about stock trading activity and compliance with disclosure rules, fitting the category of a Regulatory Filing (RNS). The document length is short (1153 characters), and it is clearly an announcement rather than a full report or financial statement.
2018-01-10 Chinese
关于持股5%以上股东减持股份进展公告
Major Shareholding Notification Classification · 100% confidence The document is an announcement regarding the progress of shareholding reduction by a shareholder holding more than 5% of the company's shares. It details the number of shares reduced, dates, prices, and compliance with relevant regulations. This fits the definition of a Major Shareholding Notification (MRQ), which involves notifications of changes in significant share ownership levels crossing thresholds. The document is not a full financial report, earnings release, or other types of filings. It is a regulatory announcement about shareholding changes.
2017-12-27 Chinese
关于获得政府补助的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (1238 characters) from a company about receiving government subsidies. It details the amounts, timing, and accounting treatment of the subsidies, but does not contain comprehensive financial statements or detailed financial analysis. It is not an annual or interim report, nor an earnings release. It is not a certification or officer attestation. The document is an announcement of a specific event (receipt of government grants) relevant to investors. Given its length and content, it fits best as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2017-12-26 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.